Regulatory environments are dynamic and can impact the drug approval process. Changes in regulations can either streamline or complicate the approval pathway. For instance, the introduction of accelerated approval programs can expedite the process for drugs that address unmet medical needs, providing a quicker route to market. Conversely, stricter regulations can increase the time and cost required for approval.